This time Digital DeskThis time in the Indian market Covid Cocktail Drug With Roche, a Swiss pharmaceutical company. The drug will enter the Indian market through Cipla, another pharmaceutical company. The drug is said to be effective in patients with mild to moderate coronary heart disease and at risk of exacerbation.

Cipla has been tasked with selling the Covid Cocktail Drug across the country. Roche and Cipla have already announced the presence of this drug in India. This experimental antibody cocktail was created by combining two drugs, Casirivimav and Imdevimab. Note that when former US President Donald Trump visited Corona in October last year (CoronaVirus) Was infected, then this medicine was given to him. In India, the drug will be priced at Rs 59,750 inclusive of tax.

On the 10th of this month, the Central Drugs Standards Control Organization (CDSCO), the country’s top drug regulator, gave permission to give this drug to patients in case of emergency. Already the first batch of this drug has been reported to have arrived in this country. The two companies have said that the second batch of the drug will be delivered to India by next June.

In the first batch, 100,000 packs of these drugs were brought to India. As a result, 2,00,000 Don’t The two organizations said in a press statement that the patient would benefit. They said that 2 corona patients can be given medicine from each pack. The drug will be available in all major hospitals and Covid-19 medical centers in the country. A multi-dose pack of medicine for two patients costs Rs 1,19,500. In other words, the cost of this drug is Rs 59,750 per patient.

Who can be given this medicine?
The pharmaceutical company claims that the dose can be given to small and medium affected patients above 12 years of age. It can also be given to patients who are at risk of serious illness but do not need oxygen. Both drug companies claim that giving these drugs before a patient’s condition worsens can prevent hospitalization and death in about 70 percent of those high-risk patients. However, some precautions have been taken in giving this medicine. If any side effects such as anaphylaxis or allergies occur in the patient’s body as a result of this medication, it is important to make sure that the medication to relieve the side effects is present at the hospital or clinic immediately.
Why don’t you do it even after getting vaccinated? Find out

These drugs can be given by injection into a patient’s vein or into the skin. It takes 20-30 minutes to give intravenously. But if given under the skin, 4 ml of 2.5 ml of Casirivimav and Imdevimab in each syringe should be given in four separate places in the patient’s abdomen and Thai. Physicians need to keep a close eye on the patient’s physical condition while administering the medication. The patient should be monitored for at least 15 minutes to 1 hour after the medication is given.

As a result of these drugs, on the one hand, it increases the body’s ability to prevent the virus from entering the body, on the other hand, it also increases the ability to fight the virus.